这种mGluR5激动剂CHPG增强了人类的寡细胞分化
Yangyang Huang1, Celine Geywitz2, Anjalika Bandaru3
1Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, 08854, USA.
药物2-chloro-5-hydroxyphenyl glycine (CHPG) 促进了人类寡细胞的成熟,这对于髓修复至关重要. 这在人类与小鼠相比,通过不同的机制发生,这对多发性硬化症 (MS) 研究有影响.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 之前在小鼠身上进行的研究表明,mGluR5激动剂CHPG通过作用于星球细胞来促进髓修复.
- 之前,CHPG对人体寡细胞及其潜在机制的影响尚不清楚.
研究的目的:
- 调查CHPG对人体寡干细胞 (OLs) 和寡干细胞前体细胞 (OPCs) 的影响.
- 为了确定mGluR5在人类OLs和OPCs中的细胞局部.
- 探索CHPG作为治疗性剂的潜力,用于治疗多发性硬化症 (MS) 等脱髓化疾病.
主要方法:
- 培养的人类诱导多能干细胞 (hiPSC) 衍生的寡干细胞和初级人类胎儿寡干细胞被CHPG治疗.
- 分析了mGluR5表达在人类的寡细胞,OPC和星球细胞中.
- 来自慢性活跃多发性硬化症患者和健康对照者的死后脑组织被分析为mGluR5表达.
主要成果:
- CHPG增加了成熟的髓基本蛋白-阳性 (MBP+) 寡类细胞的比例,但没有影响细胞存活率.
- CHPG增强了寡头细胞前体细胞 (OPC) 的增殖,并促进它们分化为成熟的寡头细胞.
- 在人类中,mGluR5表达在OPC和未成熟的寡细胞上,而不是星球细胞上,与小鼠模型形成鲜明对比.
- 多发性硬化症患者的组织在脱髓化白质内的天体细胞中显示mGluR5mRNA表达升高.
结论:
- 通过一种与在小鼠中观察到的不同机制,CHPG促进人类OPC分化和寡细胞成熟.
- 在多发性硬化症病理学中的星细胞表现出mGluR5的动态上调,这表明它在疾病进展中发挥了作用.
- 这些发现突显了CHPG在人类脱髓化疾病中用于髓修复策略的潜力.
更多相关视频
11:11Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
10:53Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
相关概念视频
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
